Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort

Ryan J Butts1,2, Gerard J Boyle3, Shriprasad R Deshpande4

  • 1Pediatric Cardiology, Medical University of South Carolina, Charleston, SC, USA. ryan.butts@utsouthwestern.edu.

Insights

This study on pediatric myocarditis found a bimodal age distribution. Gastrointestinal symptoms and reduced echo shortening fraction may predict severe outcomes in hospitalized children.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Inflammatory Heart Disease

Background:

  • Myocarditis is an inflammatory condition affecting the heart muscle in children.
  • Accurate diagnosis and risk stratification are crucial for managing pediatric myocarditis.
  • Understanding contemporary trends in pediatric myocarditis is essential for clinical practice.

Purpose of the Study:

  • To describe a current cohort of pediatric patients hospitalized with suspected myocarditis.
  • To identify factors associated with adverse outcomes, including mortality and heart transplantation.
  • To evaluate the effectiveness of immunotherapy in pediatric myocarditis.

Main Methods:

  • Retrospective chart review of 171 pediatric patients (≤18 years) with suspected myocarditis across seven tertiary hospitals (2008-2012).
  • Exclusion criteria included lack of suspected myocarditis or an alternative diagnosis.
  • Analysis of demographic data, clinical presentation, treatment, and outcomes, including mortality, transplantation, and readmission.

Main Results:

  • Pediatric myocarditis exhibited a bimodal age distribution (24% <2 years, 46% aged 13-18 years).
  • No significant difference in mortality, heart transplantation, or readmission was observed between immunotherapy groups (IVIG, steroids, both, or none).
  • Gastrointestinal symptoms and lower echocardiographic shortening fraction at admission were associated with increased risk of death or transplantation.

Conclusions:

  • Pediatric myocarditis presents with a bimodal age distribution.
  • Current immunotherapy regimens (IVIG, steroids) do not appear to influence mortality or transplantation rates.
  • Gastrointestinal symptoms and reduced echocardiographic shortening fraction are potential indicators for identifying high-risk pediatric patients with myocarditis.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
389
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
498
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
432
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
787
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
301